• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Frontiers

    Frontiers

    JournalISSN 2380-8144eISSN 2380-8144

    年发文量

    研究主题

    论文(2658)

    排序
    1Will Cognitive Offloading Affect Science’s Future?
    Frontiers Policy Labs

    As AI takes on literature review, hypothesis development, analysis and even peer review, the core skills of the scientist risk fading, much as mental arithmetic did after the calculator. Sir Peter Gluckman asks what a scientist will be, and how one will be trained, if critical thinking is increasingly offloaded to machines. Science needs to reflect urgently on which practices and norms must remain human, and on what that means for training, for society and for policy. For a full article, please click here.

    2026
    引用
    AI阅读
    加入学术空间
    2Letting Go Does Not Mean Giving Up: Science Advice in a Post-Naïve Setting
    Frontiers Policy Labs

    European science advice is mourning the loss of an ideal, simpler world and is only part way to deciding what to let go of, what to hold on to and what to create. Claire Craig, Rokia Ballo and Ruth Morgan argue that this “post-naïve” moment calls for the confidence to be uncomfortable, not retreat. Drawing on the Frontiers Policy Labs and INGSA Europe blog collection, they point to shifting models of advice, the risks and benefits of AI, the social contract for science, and the role of early career researchers. For a full article, please click here.

    2026
    引用
    AI阅读
    加入学术空间
    3The UN Has Built the Table. Now It Must Make Participation Real
    Frontiers Policy Labs

    The first UN Global Dialogue on AI Governance, held in Geneva in July 2026, gave the UN a standing political forum and an independent scientific panel on AI. Pavlina Ittelson and Seydina M. Ndiaye argue that a seat at the table is not enough if countries lack the capacity to shape the agenda. The next Secretary-General should treat capacity-building as part of the governance architecture and measure success by capability gained, not by attendance.For a full article, please click here.

    2026
    引用
    AI阅读
    加入学术空间
    4Does Adding Mean Increase? AI, Measurement and the Governance of Science
    Frontiers Policy Labs

    Adding AI to science is not automatically progress. Across funders, grant applications are surging, polished text is cheap, and the proxies for quality (effort, experience, originality) are eroding. James Wilsdon argues that more output can mean dilution unless we change what we count. Science needs to measure contribution rather than rank, fund validation as seriously as ideation, and disclose where AI is used in assessment. For a full article, please click here.

    2026
    引用
    AI阅读
    加入学术空间
    5Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Contemporary Advances in Diagnosis and Management-A Clinical Update
    Vicente Cardenas

    Background: Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders of childhood and is associated with substantial academic, behavioral, social, emotional, and health-related burdens. Contemporary care extends beyond symptom identification to include developmentally informed assessment, recognition of comorbidities, shared decision-making, and measurement-based multimodal treatment. Objective: To provide an updated, clinically oriented synthesis of current evidence on the epidemiology, neurobiology, diagnosis, differential diagnosis, comorbidities, treatment, monitoring, and long-term management of ADHD in children and adolescents. Methods: This narrative clinical review used a focused PubMed/MEDLINE search covering January 1, 2018, through August 22, 2026, supplemented by foundational publications and authoritative guidance from the American Academy of Pediatrics, National Institute for Health and Care Excellence, US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institute of Mental Health. The search identified 183 records for initial consideration. Evidence was selected purposively according to pediatric relevance, methodological rigor, clinical applicability, and regulatory status. Results: ADHD is a heterogeneous disorder arising from complex genetic, neurobiological, and environmental influences. Diagnosis remains clinical and requires developmentally inappropriate symptoms, functional impairment, childhood onset, and manifestations in more than one setting, while excluding alternative explanations. Rating scales support but do not replace comprehensive clinical assessment. Comorbid learning, anxiety, depressive, oppositional, autism spectrum, tic, sleep, and substance-use disorders can substantially influence presentation and management. Behavioral parent training is recommended as first-line treatment for preschool-aged children. For most school-aged children and adolescents with clinically significant impairment, stimulants provide the strongest evidence for reducing core symptoms, whereas atomoxetine, extended-release guanfacine, extended-release clonidine, and extended-release viloxazine are appropriate alternatives for selected patients. Effective management integrates medication when indicated with psychoeducation, behavioral strategies, school-based interventions, and treatment of comorbidities. Monitoring should address symptoms, functioning, adherence, appetite, growth, sleep, blood pressure, heart rate, mood, and medication misuse or diversion. Digital interventions may offer adjunctive benefits, but current evidence does not support replacing established treatments. Conclusions: Pediatric ADHD should be managed as a chronic, developmentally evolving condition. Accurate diagnosis, individualized multimodal treatment, systematic monitoring, and planned transition to adult services can improve symptoms and functioning. Objective biomarkers, pharmacogenomics, neurostimulation, microbiome-directed therapies, and most digital interventions remain adjunctive or investigational.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2658 篇论文

    高被引作者

    作者引用发文
    Lilla Zöllei5911
    Saad Jbabdi5911
    Allison Stevens5911
    Priti Srinivasan5911
    Timothy Behrens5911
    Augustinack Jean C5911
    Ruopeng Wang5911
    Patricia Panneck5911
    Randy L. Hirschtick (Gollub)5911
    Stefan Ehrlich5911

    高产作者

    作者引用发文
    Shuwu Liao4017
    Michael Woolf13610
    Victor Savicki1819
    jian kong19
    xilian sun08
    Han Shaogong38
    Nelson Brunsting167
    Huibing Ju247
    Melissa Whatley466
    ximi chen236

    相关期刊

    暂无数据
    暂无数据